Search for: "Walter v. Walter" Results 121 - 140 of 2,633
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Apr 2023, 9:22 am by Miquel Montañá (Clifford Chance)
In this regard, in its judgment of 12 December 2013 (case C-493/12, Eli Lilly v Human Genome Sciences), the CJEU made the following observations: “30. [read post]
26 Apr 2023, 11:31 am by admin
One example, the appellate decision in Rosen v. [read post]
It is superfluous for cases such as Ericsson v Apple, costly and lengthy for the litigants, and clogs the court system. [read post]
8 Apr 2023, 3:50 am by Bart van Wezenbeek (Hoffmann Eitle)
More from our authors: Vissers Annotated European Patent Convention 2022 Edition by Kaisa Suominen, Peter de Lange, Andrew Rudge€ 105 Guide to EU and UK Pharmaceutical Regulatory Law, Eighth Edition by Sally Shorthose€ 265 The Digital Economy and International Trade: Transnational Data Flows Regulation … [read post]
The judge reviewed the national case law on selections/deletions from multiple lists (Merck v Shionogi [2016] EWHC 2989 (Pat), Nokia v IPCom [2012] EWCA Civ 567 and GlaxoSmithKline v Wyeth [2016] EWHC 1045 (Pat)) and the EPO cases reviewed therein and in the EPO Case Law Book. [read post]
4 Apr 2023, 7:38 am
“With the rapid proliferation of LLM models, we are in a new era where content is king,” said Fastcase CEO Ed Walters. [read post]
4 Apr 2023, 7:27 am by Nicole Indelicato
In 2023, Oakley raised a record €2.85 billion for Oakley Capital Fund V, bringing their total AUM to €8 billion. [read post]
The most famous decision might be the UK Supreme Court’s Ruling in Warner-Lambert Company LLC v Generics (UK) Ltd, which was reported on this blog here. [read post]
On 16 March 2022, the High Court of England and Wales handed down its judgment following the FRAND trial in InterDigital v Lenovo. [read post]
27 Mar 2023, 8:18 am by Nicholas Round (Bristows)
On 16 March 2023, the High Court of England and Wales handed down its judgment following the FRAND trial in InterDigital v Lenovo. [read post]
As an example, it can be a sign of infringement if the marketing strategy induces doctors to prescribe the generic for the omitted therapeutic indication (GlaxoSmithKline v. [read post]
19 Mar 2023, 12:56 pm by Giles Peaker
As famously expressed by Knight Bruce V-C in Walter v Selfe (1851) 4 De G & Sm 315, 322, the question is whether the interference ought to be considered a material inconvenience “not merely according to elegant or dainty modes and habits of living, but according to plain and sober and simple notions among the English people”; see also Barr v Biffa Waste Services Ltd (2013) QB 455, para 36(ii). [read post]